Trial Profile
Biochemical and neuropsychological effects on Premenstrual Dysphoric Disorder after acute administration of escitalopram
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Apr 2016
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Social phobia
- Focus Pharmacodynamics
- 21 Apr 2016 New trial record